Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE275.3600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots110.6900/ 1
- Ask / Lots440.5700/ 2
- Open / Previous Close0.0000 / 275.3600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 1540 | 279 |
| 09:36 ET | 100 | 276.235 |
| 09:38 ET | 741 | 276.61 |
| 09:39 ET | 200 | 275.7042 |
| 09:41 ET | 944 | 277.33 |
| 09:43 ET | 759 | 275.73 |
| 09:50 ET | 1700 | 275.29 |
| 09:52 ET | 2387 | 276 |
| 09:54 ET | 375 | 275.865 |
| 09:57 ET | 500 | 275.62 |
| 09:59 ET | 200 | 275.78 |
| 10:01 ET | 500 | 275.55 |
| 10:03 ET | 639 | 275.63 |
| 10:06 ET | 1100 | 275.71 |
| 10:08 ET | 500 | 275.17 |
| 10:10 ET | 400 | 274.02 |
| 10:12 ET | 843 | 274.63 |
| 10:15 ET | 200 | 273.655 |
| 10:17 ET | 499 | 273.465 |
| 10:19 ET | 400 | 273.065 |
| 10:21 ET | 5800 | 272.44 |
| 10:24 ET | 100 | 272.03 |
| 10:26 ET | 900 | 272.43 |
| 10:28 ET | 400 | 273.685 |
| 10:30 ET | 200 | 272.81 |
| 10:32 ET | 675 | 271.9 |
| 10:33 ET | 300 | 271.33 |
| 10:35 ET | 950 | 270.89 |
| 10:37 ET | 100 | 270.1 |
| 10:39 ET | 600 | 269.985 |
| 10:42 ET | 1400 | 270 |
| 10:44 ET | 2007 | 268.42 |
| 10:46 ET | 1200 | 268.285 |
| 10:48 ET | 991 | 267.68 |
| 10:50 ET | 100 | 267.68 |
| 10:51 ET | 1108 | 269.03 |
| 10:53 ET | 1650 | 268.66 |
| 10:55 ET | 340 | 269.785 |
| 10:57 ET | 669 | 270.48 |
| 11:00 ET | 300 | 270.84 |
| 11:02 ET | 300 | 270.75 |
| 11:04 ET | 400 | 270.973 |
| 11:06 ET | 600 | 271.64 |
| 11:08 ET | 4550 | 271.495 |
| 11:09 ET | 659 | 271.03 |
| 11:11 ET | 750 | 270.275 |
| 11:13 ET | 700 | 270.87 |
| 11:15 ET | 100 | 271.055 |
| 11:18 ET | 200 | 271.725 |
| 11:20 ET | 290 | 272.57 |
| 11:22 ET | 659 | 272.275 |
| 11:24 ET | 599 | 273.56 |
| 11:26 ET | 500 | 272.64 |
| 11:27 ET | 300 | 273.25 |
| 11:29 ET | 401 | 272.99 |
| 11:31 ET | 1505 | 272.49 |
| 11:33 ET | 100 | 271.89 |
| 11:36 ET | 1300 | 271.35 |
| 11:38 ET | 100 | 270.87 |
| 11:40 ET | 200 | 270.36 |
| 11:42 ET | 1466 | 270.155 |
| 11:45 ET | 245 | 271.33 |
| 11:49 ET | 300 | 271.925 |
| 11:51 ET | 421 | 273.49 |
| 11:54 ET | 200 | 272.645 |
| 11:56 ET | 752 | 274.64 |
| 12:00 ET | 700 | 273.935 |
| 12:02 ET | 400 | 274.56 |
| 12:07 ET | 280 | 274.77 |
| 12:09 ET | 100 | 274.885 |
| 12:12 ET | 1328 | 275.5 |
| 12:14 ET | 420 | 275.5 |
| 12:18 ET | 1389 | 276.9888 |
| 12:20 ET | 100 | 276.64 |
| 12:21 ET | 600 | 276.615 |
| 12:23 ET | 3483 | 277.33 |
| 12:25 ET | 200 | 277.61 |
| 12:27 ET | 450 | 277.28 |
| 12:30 ET | 200 | 277.56 |
| 12:32 ET | 900 | 276.845 |
| 12:34 ET | 100 | 276.8 |
| 12:36 ET | 101 | 276.4101 |
| 12:38 ET | 200 | 276.635 |
| 12:39 ET | 200 | 276.31 |
| 12:41 ET | 400 | 276.28 |
| 12:43 ET | 100 | 276.45 |
| 12:45 ET | 970 | 277.62 |
| 12:50 ET | 700 | 276.68 |
| 12:52 ET | 100 | 276.505 |
| 12:54 ET | 900 | 275.99 |
| 12:57 ET | 100 | 275.75 |
| 01:01 ET | 300 | 275.09 |
| 01:03 ET | 100 | 274.87 |
| 01:10 ET | 100 | 273.805 |
| 01:12 ET | 200 | 274.5 |
| 01:14 ET | 473 | 274.93 |
| 01:15 ET | 800 | 274.44 |
| 01:21 ET | 300 | 273.08 |
| 01:32 ET | 400 | 272.79 |
| 01:33 ET | 486 | 273.66 |
| 01:42 ET | 200 | 273.835 |
| 01:44 ET | 600 | 273.78 |
| 01:50 ET | 100 | 273.17 |
| 01:51 ET | 600 | 273.7 |
| 01:57 ET | 100 | 274.065 |
| 02:00 ET | 200 | 274.075 |
| 02:02 ET | 500 | 274.2 |
| 02:04 ET | 200 | 273.66 |
| 02:06 ET | 900 | 274.18 |
| 02:13 ET | 700 | 274.59 |
| 02:15 ET | 400 | 273.85 |
| 02:18 ET | 200 | 273.87 |
| 02:20 ET | 100 | 273.305 |
| 02:22 ET | 311 | 272.565 |
| 02:24 ET | 742 | 272.18 |
| 02:26 ET | 1000 | 271.42 |
| 02:27 ET | 100 | 271.57 |
| 02:29 ET | 1489 | 271.0907 |
| 02:31 ET | 442 | 271.34 |
| 02:33 ET | 2401 | 272.09 |
| 02:36 ET | 1653 | 272.07 |
| 02:38 ET | 100 | 272.09 |
| 02:40 ET | 300 | 273 |
| 02:44 ET | 300 | 273.54 |
| 02:47 ET | 100 | 274.225 |
| 02:51 ET | 500 | 273.715 |
| 02:54 ET | 100 | 273.5 |
| 02:56 ET | 200 | 273.55 |
| 02:58 ET | 912 | 273.83 |
| 03:00 ET | 810 | 274.16 |
| 03:02 ET | 300 | 273.78 |
| 03:07 ET | 274 | 273.9284 |
| 03:09 ET | 300 | 273.585 |
| 03:12 ET | 200 | 273.2 |
| 03:14 ET | 1035 | 273.235 |
| 03:16 ET | 100 | 273.26 |
| 03:18 ET | 300 | 273.24 |
| 03:20 ET | 424 | 273.42 |
| 03:21 ET | 100 | 273.55 |
| 03:25 ET | 1100 | 274 |
| 03:27 ET | 100 | 273.79 |
| 03:30 ET | 100 | 273.84 |
| 03:32 ET | 300 | 273.8 |
| 03:34 ET | 823 | 273.7501 |
| 03:36 ET | 1200 | 274.35 |
| 03:38 ET | 900 | 274.72 |
| 03:39 ET | 1184 | 274.63 |
| 03:41 ET | 2300 | 274.835 |
| 03:43 ET | 1400 | 274.85 |
| 03:45 ET | 1029 | 274.6925 |
| 03:48 ET | 400 | 274.66 |
| 03:50 ET | 3212 | 274.72 |
| 03:52 ET | 1651 | 274.955 |
| 03:54 ET | 1500 | 274.85 |
| 03:56 ET | 5687 | 274.33 |
| 03:57 ET | 4715 | 275.34 |
| 03:59 ET | 3937 | 275.36 |
Jun 6, 2024
Jun 5, 2024
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference, from 8:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
8:00AM ET on Wednesday Jun 05, 2024 by Dow JonesDJ S&P 500 Futures Rise In Premarket Trading; Hewlett Packard Ent, CrowdStrike Holdings Lead, from 7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
May 29, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 6.0B | -11.9x | --- |
Cytokinetics Inc | 6.1B | -9.6x | --- |
Summit Therapeutics Inc | 5.5B | -46.9x | --- |
Revolution Medicines Inc | 6.4B | -10.2x | --- |
Viking Therapeutics Inc | 5.2B | -50.9x | --- |
Nuvalent Inc | 5.2B | -32.7x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Chief Commercial Officer
- Carole Huntsman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.43 |
EPS | $-23.08 |
Book Value | $20.39 |
P/E Ratio | -11.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
